UTMD — Utah Medical Products Balance Sheet
0.000.00%
- $172.82m
- $89.84m
- $40.90m
- 92
- 68
- 40
- 74
Annual balance sheet for Utah Medical Products, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 51.6 | 61 | 75.1 | 92.9 | 83 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.1 | 5.13 | 5.54 | 3.39 | 4.09 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 62.3 | 73.2 | 89.9 | 106 | 96.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 11.3 | 11.1 | 10.2 | 10.6 | 9.76 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Total Assets | 112 | 116 | 124 | 135 | 123 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.79 | 3.75 | 5.96 | 4.71 | 3.76 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.92 | 8.5 | 9.62 | 7.14 | 5.11 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 103 | 107 | 114 | 128 | 117 |
Total Liabilities & Shareholders' Equity | 112 | 116 | 124 | 135 | 123 |
Total Common Shares Outstanding |